Table 1.
First author | Country | Year | N | Study design | No. of centres | Demographics | FVC % (mean) | Diagnostic yield (%) | IPF diagnosis (%) | Complications (%) | 30-Day mortality (%) | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Age (mean) | Gender (%) | Histological | MDT | Pneumothorax | Bleeding | ||||||||||
Babiak [22] | Germany | 2009 | 41 | Retrospective | Case series | Single | NR | NR | NR | NR | 95.1 | 39.0 | 4.87 | 0.0 | NR |
Kropski [48] | USA | 2013 | 25 | Retrospective | Case series | Single | 57.1 | 52 | 75.3 | NR | 76.0 | 28.0 | 0.0 | 0.0 | NR |
Casoni [24] | Italy | 2014 | 69 | Prospective | Observational cohort study | Single | 60a | 51 | 81a | 93 | NR | 57d | 28 | 1.4 | 1.4 |
Fruchter [38] | Israel | 2014 | 75 | Retrospective | Case series | Single | 56.2 | 55 | NR | 70 | 98 | 9.3 | 0.0 | 0.0 | NR |
Griff [41] | Germany | 2014 | 52 | Retrospective | Case series | Single | 63a | 69 | NR | 79 | 79 | 25 | 0.0 | 0.0 | NR |
Pajares [56] | Spain | 2014 | 39 | Prospective | Randomised control trial | Single | 60.3 | 51 | 78.2 | 74.4 | 51.4 | 0.0 | 7.7 | 56.4 | NR |
Hernandez-Gonzalez [42] | Spain | 2015 | 33 | Retrospective | Case series | Single | 64 | 33 | 69 | 79 | 88 | 12 | 12 | 21 | NR |
Cascante [51] | Spain | 2016 | 55 | Prospective | Observational cohort study | Single | 58.8 | 58.1 | 79.7 | NR | 87.3 | 32.7 | 14.5 | 10.9 | 0.0 |
Echevarria-Uraga [50] | Spain | 2016 | 100 | Retrospective | Case series | Single | 63a | 66 | 85a | NR | 97.6 | 11.0 | 3 | 13 | 1e |
Hagmeyer [64] | Germany | 2016 | 32 | Retrospective | Case series | Single | 65.4 | 68.8 | 74.6 | NR | 72 | NR | 19 | 78 | NR |
Hagmeyer [63] | Germany | 2016 | 19 | Prospective | Observational cohort study | Single | 67a | 63 | 80a | NR | 78 | NR | 26 | 79 | 5.3 |
Ravaglia [45] | Italy | 2016 | 297 | Retrospective | Observational cohort study | Single | 60a | 57.9 | 86.0a | 82.8 | NR | NR | 20.20 | 0.0 | 0.3e |
Tomassetti [49] | Italy | 2016 | 58 | Retrospective | Cross-sectional study | Single | 59a | 47 | 82a | NR | 94.8 | 50.0 | 33 | 0.0 | 1.7e |
Almeida [44] | Portugal | 2017 | 100 | Retrospective | Case series | Single | 57.15 | 64 | 90.0a | 82 | NR | 9.0 | 18.0 | 3.0 | 1.0 |
Bango-Alvarez [29] | Spain | 2017 | 106 | Prospective | Observational cohort study | Single | 60 | 65 | 76.4 | NR | 86 | 20.8 | 4.7 | 16 | NR |
DiBardino [36] | USA | 2017 | 17 | Retrospective | Case series | Single | NR | NR | NR | 53 | 82 | 5.9 | 11.8 | 17.6 | 0.0 |
Kronberg-White [27] | Denmark | 2017 | 38 | Retrospective | Case series | Single | 61a | 58 | 87 | 84.2 | 97.4 | 26.3 | 26 | 16 | 0.0e |
Marçâo [39] | Portugal | 2017 | 90 | Retrospective | Case series | Single | 60 | 58.9 | 85a | 73.3 | 70.5 | 8.1 | 22.4 | 5.6 | NR |
Sriprasart [47] | USA | 2017 | 74 | Retrospective | Case series | Single | 54 | 49 | NR | 87.84 | NR | 14.9 | 6.8 | 4.1 | 4.1 |
Ussavarungsi [35] | USA | 2017 | 74 | Retrospective | Case series | Single | 63 | 55 | NR | 51 | 79.7 | NR | 1.4 | 12.2 | 0.0 |
Cooley [37] | USA | 2018 | 159 | Retrospective | Observational cohort study | Single | 57 | 46 | 70 | 69 | 79 | 6.9 | 11 | 3.8 | 1.9 |
Hagmeyer [72] | Germany | 2018 | 42 | Prospective | Observational cohort study | Single | 66 | 57 | 82 | NR | 76.2 | NR | 12 | 0 | 2 |
Lentz [34] | USA | 2018 | 104 | Retrospective | Case series | Single | 58.2 | 55.8 | 70.2 | 44.2 | 68.3 | 21.2 | 2.9 | 3.8 | NR |
Cho [46] | USA | 2019 | 40 | Retrospective | Case series | Single | 57.2 | 70 | 68.51 | 85 | NR | 2.5 | 0 | 10 | 0 |
Kuse [40] | Japan | 2019 | 38 | Retrospective | Case series | Single | 71b | 68b | NR | 74 | 92 | 7.9 | 0.0 | 0.0 | 0.0e |
Ravaglia [54] | Italy | 2019 | 699 | Retrospective | Observational cohort study | Single | 61a | 59.1 | 85.4 | 87.8 | 90.1 | 35.1 | 19.2 | 8.3 | 0.4 |
Romagnoli [61] | France/Italy | 2019 | 21 | Prospective | Single group assignment study | Two | 65a | 48 | 80.05 | 38c | 48 | 42.9 | 9.5 | 0.0 | NR |
Samitas [43] | Greece | 2019 | 50 | Retrospective | Case series | Single | 61 | 58 | 69.7 | 80 | 76 | 6.0 | 10 | 24 | NR |
Wäscher [62] | Germany | 2019 | 109 | Retrospective | Case series | Single | 64a | 66 | 77a | 73.4 | 83.5 | 8.3 | 11.9 | 28.4 | 0.0 |
IPF idiopathic pulmonary fibrosis, MDT multidisciplinary team, NR not reported
aReported as median
bMixed cohort of IPF and lung malignancy patients
cDiagnostic accuracy
dIncludes possible IPF
eDid not specify 30-day mortality